Øivind Midttun1, Arve Ulvik1, Ottar Nygård2,3, Per M Ueland4,3. 1. Bevital AS, Bergen, Norway. 2. Department of Heart Disease. 3. Department of Clinical Science, University of Bergen, Bergen, Norway. 4. Laboratory of Clinical Biochemistry, Haukeland University Hospital, Bergen, Norway.
Abstract
Background: Coffee is a widely consumed beverage, and studies suggest that drinking coffee has beneficial health effects. The phytohormone trigonelline is present in large amounts in coffee beans, and circulating concentrations of trigonelline have been shown to be positively related to dietary intake of coffee and to increase significantly after the consumption of a bolus dose of coffee. Objective: We cross-sectionally investigated the utility of plasma trigonelline as a marker of coffee consumption in an epidemiologic setting. We secondarily investigated if coffee intake is related to plasma concentrations of vitamin B-3 (niacin) forms. Design: In a Norwegian cohort of 3503 participants, we combined questionnaire data on the number of cups of coffee consumed per day with plasma trigonelline to evaluate trigonelline as a marker of coffee intake. The suitability of plasma trigonelline to discriminate those not consuming from those consuming coffee was investigated by receiver operating characteristic (ROC) analysis. Plasma collected at 2 time points 1 y apart was used to determine the within-person reproducibility of trigonelline. Results: We found that plasma trigonelline concentrations increased strongly with increasing amounts of coffee consumed. ROC analysis showed that trigonelline had an area under the curve of 0.92 (95% CI: 0.90, 0.94) for distinguishing coffee abstainers from coffee drinkers. Plasma trigonelline had a good within-person reproducibility (0.66; 95% CI: 0.64, 0.68) for samples collected 1 y apart. The amount of coffee consumed was not associated with plasma concentrations of the niacin vitamers nicotinamide and N1-methylnicotinamide. Conclusions: Plasma trigonelline performs well as a marker of coffee intake. Data used in this study were derived from the clinical trial registered at www.clinicaltrials.gov as NCT00354081.
Background: Coffee is a widely consumed beverage, and studies suggest that drinking coffee has beneficial health effects. The phytohormone trigonelline is present in large amounts in coffee beans, and circulating concentrations of trigonelline have been shown to be positively related to dietary intake of coffee and to increase significantly after the consumption of a bolus dose of coffee. Objective: We cross-sectionally investigated the utility of plasma trigonelline as a marker of coffee consumption in an epidemiologic setting. We secondarily investigated if coffee intake is related to plasma concentrations of vitamin B-3 (niacin) forms. Design: In a Norwegian cohort of 3503 participants, we combined questionnaire data on the number of cups of coffee consumed per day with plasma trigonelline to evaluate trigonelline as a marker of coffee intake. The suitability of plasma trigonelline to discriminate those not consuming from those consuming coffee was investigated by receiver operating characteristic (ROC) analysis. Plasma collected at 2 time points 1 y apart was used to determine the within-person reproducibility of trigonelline. Results: We found that plasma trigonelline concentrations increased strongly with increasing amounts of coffee consumed. ROC analysis showed that trigonelline had an area under the curve of 0.92 (95% CI: 0.90, 0.94) for distinguishing coffee abstainers from coffee drinkers. Plasma trigonelline had a good within-person reproducibility (0.66; 95% CI: 0.64, 0.68) for samples collected 1 y apart. The amount of coffee consumed was not associated with plasma concentrations of the niacin vitamers nicotinamide and N1-methylnicotinamide. Conclusions: Plasma trigonelline performs well as a marker of coffee intake. Data used in this study were derived from the clinical trial registered at www.clinicaltrials.gov as NCT00354081.
Authors: Joram M Posma; Isabel Garcia-Perez; Gary Frost; Ghadeer S Aljuraiban; Queenie Chan; Linda Van Horn; Martha Daviglus; Jeremiah Stamler; Elaine Holmes; Paul Elliott; Jeremy K Nicholson Journal: Nat Food Date: 2020-06-22
Authors: Yuko Yamaguchi; Marta Zampino; Ruin Moaddel; Teresa K Chen; Qu Tian; Luigi Ferrucci; Richard D Semba Journal: Metabolomics Date: 2021-01-11 Impact factor: 4.747
Authors: Christopher Papandreou; Pablo Hernández-Alonso; Mònica Bulló; Miguel Ruiz-Canela; Edward Yu; Marta Guasch-Ferré; Estefanía Toledo; Courtney Dennis; Amy Deik; Clary Clish; Cristina Razquin; Dolores Corella; Ramon Estruch; Emilio Ros; Montserrat Fitó; Fernando Arós; Miquel Fiol; José Lapetra; Cristina Ruano; Liming Liang; Miguel A Martínez-González; Frank B Hu; Jordi Salas-Salvadó Journal: Nutrients Date: 2019-05-08 Impact factor: 5.717
Authors: Grace F Crotty; Romeo Maciuca; Eric A Macklin; Junhua Wang; Manuel Montalban; Sonnet S Davis; Jamal I Alkabsh; Rachit Bakshi; Xiqun Chen; Alberto Ascherio; Giuseppe Astarita; Sarah Huntwork-Rodriguez; Michael A Schwarzschild Journal: Neurology Date: 2020-09-30 Impact factor: 9.910